FoxBio Company
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
Founded Date:
2018
Last Funding Type:
Venture - Series Unknown
Headquarters:
Lafayette, Louisiana, United States
Investors Number:
2
Technology:
Geroscience
Industry:
Biopharma, Biotechnology, Life Science
Last Funding Date:
2018
Number Of Exists:
Venture - Series Unknown
Investor Type:
Company
Total Funding:
10000000